Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines

Author:

Anderson IM1,Ferrier IN2,Baldwin RC3,Cowen PJ4,Howard L5,Lewis G6,Matthews K7,McAllister-Williams RH8,Peveler RC9,Scott J10,Tylee A11

Affiliation:

1. Senior Lecturer and Honorary Consultant Psychiatrist, Neuroscience and Psychiatry Unit, University of Manchester, UK,

2. Honorary Consultant Psychiatrist, School of Neurology, Neurobiology and Psychiatry, Newcastle University, Royal Victoria Infirmary, Newcastle upon Tyne, UK

3. Manchester Mental Health and Social Care Trust, Manchester Royal Infirmary, UK

4. The Psychopharmacology Research Unit, University Department of Psychiatry, Warneford Hospital, Oxford, UK

5. Department, Institute of Psychiatry, King's College London, De Crespigny Park, London, UK

6. Academic Unit of Psychiatry, Cotham House, Bristol, UK

7. Section of Psychiatry and Behavioural Sciences, Division of Pathology and Neuroscience, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK

8. Institute of Neuroscience, Newcastle University, Royal Victoria Infirmary, Newcastle upon Tyne, UK

9. University of Southampton, Royal South Hants Hospital, Southampton, UK

10. Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK

11. NIHR Biomedical Research Centre and Health Services and Population Research Department, Institute of Psychiatry, Kings College London, London, UK

Abstract

A revision of the 2000 British Association for Psychopharmacology evidence-based guidelines for treating depressive disorders with antidepressants was undertaken to incorporate new evidence and to update the recommendations where appropriate. A consensus meeting involving experts in depressive disorders and their management was held in May 2006. Key areas in treating depression were reviewed, and the strength of evidence and clinical implications were considered. The guidelines were drawn up after extensive feedback from participants and interested parties. A literature review is provided, which identifies the quality of evidence to inform the recommendations, the strength of which are based on the level of evidence. These guidelines cover the nature and detection of depressive disorders, acute treatment with antidepressant drugs, choice of drug versus alternative treatment, practical issues in prescribing and management, next-step treatment, relapse prevention, treatment of relapse, and stopping treatment.

Publisher

SAGE Publications

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology

Cited by 386 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3